DSP and cardiomyopathy: In a multicenter study that compared the clinical features of patients with DSP and PKP2 genetic variants, the 2010 ITF criteria were insensitive for diagnosing ACM in DSP carriers (34% vs. 49%, p = 0.02), despite the presence of clinically confirmed cardiomyopathy [17].